EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications

Shuangjie Qian, Jialong Hou, Xi Xiong, Qi Duan, Tao Jiang, Yi Zheng, Weiwei Quan, Jiaxue Xu, Keke Chen, Jingjing Qian, Hongchang Gao iD, Chenglong Xie iD

CNS Neuroscience & Therapeutics · 2026

DOI: 10.1002/cns.70750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Shuangjie Qian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Parkinson Disease, Dysbiosis, Feces, Metabolome. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Projects of the National Science Foundation of China, the Projects of the Natural Science Foundation of Zhejiang Province, Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease with motor complications (PD‐MC) lacks effective diagnostic and therapeutic strategies. The perturbations of the gut microbiota and plasma metabolites are closely associated with the etiopathogenesis of PD. However, whether fecal microbiome dysbiosis and changed plasma metabolites are involved in PD progression, particularly in the development of PD‐MC, is still unclear.

Methods

In this study, we performed an extensive multiomics analysis involving 108 PD patients for 16S rRNA gut microbiome profiling and 246 PD patients for plasma nontargeted metabolomics. Our findings revealed distinct gut microbiota and plasma metabolites associated with PD‐MC. Utilizing these discriminative features, we developed a multivariate diagnostic model for PD‐MC. The relationships between differential metabolites and microorganisms were evaluated using Spearman correlation analysis. Functional interpretation of the key metabolites was conducted through enrichment and pathway analysis, employing the KEGG and SMPDB databases.

Results

PD‐MC patients had distinct gut microbial signatures as compared with PD without motor complications (PD‐NMC) individuals and were increased in fecal Lactobacillus, Limosilactobacillus, Bifidobacterium, and Ligilactobacillus genera along with depleted Agathobacter. Moreover, metabolomic analysis revealed the differences in plasma 3‐deoxysappanchalcone (3‐DSC), 1,3‐Dimethyluracil (1,3‐DTl), Leucine, and N‐Acetylisoleucine (N‐AIL), Dodec‐6‐enoic acid (D‐6‐E), N‐butyl Oleate (N‐BO), and 4‐hydroxyundecanoic acid (4‐HUA) in PD‐MC compared to PD‐NMC. Spearman correlation analysis showed that the fecal microbiota aberrations in PD‐MC patients were linked to plasma metabolic changes, indicating the association between key microbial populations and metabolomic profiles in PD‐MC.

Conclusions

This study underscores the value of employing integrated multiomics profiling of the fecal microbiome and plasma metabolome to enhance the mechanistic understanding of PD‐MC and to identify potential diagnostic biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseDysbiosisFecesMetabolomeGastrointestinal MicrobiomeHumansMaleFemaleAgedMiddle AgedMultiomics

Stichwörter der Autor:innen

Parkinson's diseasefecal microbiomemotor complicationsmultiomics biomarkersplasma metabolome

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Key Laboratory of Alzheimer's Disease of Zhejiang Province, Institute of Aging, Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Oujiang Laboratory, Wenzhou, Zhejiang, China.
  • Department of Geriatrics, Geriatric Medical Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

ORCID-Profile: Hongchang Gao, Chenglong Xie

Förderung

  • Projects of the National Science Foundation of China
  • the Projects of the Natural Science Foundation of Zhejiang Province
  • Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang
  • the "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province
  • The Projects of the Wenzhou City Committee of Science and Technology

Zitieren

APA

Qian, S., Hou, J., Xiong, X., Duan, Q., Jiang, T., Zheng, Y., Quan, W., Xu, J., Chen, K., Qian, J., Gao, H., & Xie, C. (2026). Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70750

Vancouver

Qian S, Hou J, Xiong X, Duan Q, Jiang T, Zheng Y, et al. Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70750

BibTeX
@article{Qian2026,
  author = {Qian, Shuangjie and Hou, Jialong and Xiong, Xi and Duan, Qi and Jiang, Tao and Zheng, Yi and Quan, Weiwei and Xu, Jiaxue and Chen, Keke and Qian, Jingjing and Gao, Hongchang and Xie, Chenglong},
  title = {Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  doi = {10.1002/cns.70750}
}
Kostenlos starten →